Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and strong double-digit top-line growth despite sector headwinds. Recent FQ3 2025 results showed a double-beat, with revenue up 12% year-over-year and EPS surpassing analyst estimates, signaling a turnaround.
Merck offers strong dividend growth, a robust drug pipeline, and strategic acquisitions, positioning it well beyond Keytruda's patent expiration. MRK's 3.9% dividend yield, low payout ratio, and A+ credit rating support its 14-year dividend growth streak and future income potential. Elevance Health faces near-term headwinds but boasts a large consumer base, efficiency initiatives, and a 13-year dividend growth record.
Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation if growth continues from 2026. The key risk remains a health benefit ratio above 90%, which will be closely monitored in upcoming quarters.
| - Industry | - Sector | Gail Koziara Boudreaux CEO | XMIL Exchange | US0367521038 ISIN |
| US Country | 104,200 Employees | 5 Dec 2025 Last Dividend | 1 Jun 2005 Last Split | 2 Jan 2001 IPO Date |
Elevance Health, Inc., operating in the United States, is a comprehensive health benefits organization that was established in 2001. Initially known as Anthem, Inc., the company underwent a name change to Elevance Health, Inc. in June 2022, marking a new era in its operation. Headquartered in Indianapolis, Indiana, Elevance Health extends its services through a range of health plans and insurance products. The company's operations are segmented into four main divisions: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other, reflecting its vast spectrum of offerings in the health sector. Elevance Health is a key player in the health benefits space, leveraging its extensive network and services to cater to the diverse needs of its program members.
Elevance Health provides a variety of health plans, including managed care services on a fee basis, catering to the needs of its members. This segment ensures access to quality healthcare and supports the wellbeing of individuals under its care.
Offering more than traditional health insurance, the company extends its portfolio to include stop loss, dental, vision, life, disability, and supplemental health insurance benefits. These products are designed to offer comprehensive coverage and peace of mind to members.
Under its CarelonRx segment, Elevance Health operates in the pharmacy services business, providing crucial services like pharmacy benefit management, home delivery and specialty pharmacies, formulary management, pharmacy networks, and rebate administration. This comprehensive approach ensures accessibility and affordability of prescription medications.
The company also excels in delivering a wide range of healthcare-related services, including but not limited to utilization management, behavioral health, integrated care delivery, and palliative care. Additionally, it offers payment integrity services, subrogation services, and health and wellness programs, emphasizing its commitment to overall health management and cost containment.
Through its involvement in the National Government Services business, Elevance Health plays a crucial role in servicing government health programs. This segment underscores the company's expertise and capacity to handle large-scale, government-sponsored health initiatives efficiently.
Elevance Health serves its clients under well-established brand names such as Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon, aligning its diverse service offerings with trusted and recognized brands in the health industry.